Business News

Mendus narrows Q2 loss as blood cancer trials advance

FinSiddhi

Mendus narrows Q2 loss as blood cancer trials advance
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

Jey Uso, Jimmy Uso and Solo Sikoa’s combined net worth in 2026: Inside the WWE stars’ salaries, earnings, merchandise, endorsements and Anoa’i family fortune

Jey Uso, Jimmy Uso and Solo Sikoa have made a lot of money thanks to their WWE contracts, merchandise, premium live event appearances and the commercial power of the Anoa’i wrestling dynasty. While Jey’s singles success has boosted his earning power, Jimmy’s tag-team legacy and Solo’s growing profile all add to the family’s financial picture….

Elon Musk likely to face tough questions during SpaceX’s first earnings call after stock market listing

SpaceX’s investors are gearing up to challenge Elon Musk about the company’s trajectory and financial stability as stock prices have plummeted since June’s highs. Anticipated insider share sales could amplify trading fluctuations. Investors are particularly interested in Musk’s insights on the Starship rocket launch tests and satellite network developments, especially given that SpaceX is grappling…